Towards exploring the topological structure of data, numerous graph embedding clustering methods have been developed in recent years, none of them takes into account the cluster-specificity distribution of the nodes representations, resulting in suboptimal clustering performance. Moreover, most existing graph embedding clustering methods execute the nodes representations learning and clustering in two separated steps, which increases the instability of its original performance. Additionally, rare of them simultaneously takes node attributes reconstruction and graph structure reconstruction into account, resulting in degrading the capability of graph learning. In this work, we integrate the nodes representations learning and clustering into a unified framework, and propose a new deep graph attention auto-encoder for nodes clustering that attempts to learn more favorable nodes representations by leveraging self-attention mechanism and node attributes reconstruction. Meanwhile, a cluster-specificity distribution constraint, which is measured by ℓ1,2-norm, is employed to make the nodes representations within the same cluster end up with a common distribution in the dimension space while representations with different clusters have different distributions in the intrinsic dimensions. Extensive experiment results reveal that our proposed method is superior to several state-of-the-art methods in terms of performance.Distant supervision relation extraction methods are widely used to extract relational facts in text. The traditional selective attention model regards instances in the bag as independent of each other, which makes insufficient use of correlation information between instances and supervision information of all correctly labeled instances, affecting the performance of relation extractor. Aiming at this problem, a distant supervision relation extraction method with self-selective attention is proposed. The method uses a layer of convolution and self-attention mechanism to encode instances to learn the better semantic vector representation of instances. The correlation between instances in the bag is used to assign a higher weight to all correctly labeled instances, and the weighted summation of instances in the bag is used to obtain a bag vector representation. Experiments on the NYT dataset show that the method can make full use of the information of all correctly labeled instances in the bag. The method can achieve better results as compared with baselines. Psychogenic nonepileptic attacks (PNEA) are events of altered behavior that resemble epileptic seizures (ES) but are not caused by abnormal electrical cortical activity. Understanding which clinical signs and symptoms are associated with PNEA may allow better triaging for video-electroencephalogram monitoring (VEM) and for a more accurate prediction when such testing is unavailable. We performed a systematic review searching Medline, Embase, and Cochrane Central from inception to March 29, 2019. We included original research that reported at least one clinical sign or symptom, included distinct groups of adult ES and PNEA with no overlap, and used VEM for the reference standard. Two authors independently assessed quality of the studies using the Quality Assessment of Diagnostic Accuracy Studies tool. Pooled estimates of sensitivity and specificity of studies were evaluated using a bivariate random effects model. We identified 4028 articles, of which 33 were included. There was a female sex predominance ultisource predictive tools to optimize diagnostic likelihood ratios. This review reflects the limited certainty afforded by individual clinical features to distinguish between PNEA and ES. Specific demographic and comorbid features, even despite moderately high specificities, impart minimal impact on diagnostic decision making. This emphasizes the need for the development of multisource predictive tools to optimize diagnostic likelihood ratios. We performed a systematic review to evaluate available risk models to predict late seizure onset among stroke survivors. We searched major databases (PubMed, SCOPUS, and Cochrane Library) from inception to October 2020 for articles on the development and/or validation of risk models to predict late seizures after a stroke. The impact of models to predict late-onset seizures was also assessed. We included seven articles in the final analysis. For each of these studies, we evaluated the study design and scope of predictors analyzed to derive each model. We assessed the performance of the models during internal and external validation in terms of discrimination and calibration. Three studies focused on ischemic stroke alone, with c-statistic values ranging from 0.73 to 0.77. https://www.selleckchem.com/products/tpx-0005.html The SeLECT model from Switzerland was externally validated in Italian, German, and Austrian cohorts where c-statistics ranged from 0.69 to 0.81. This model along with the PSEiCARe model, were internally validated and calibration perforted in a very similar and homogeneous population, may need to be tested in a more racially/ethnic diverse and younger population; testing the SeLECT model, accounting for overall brain health is likely to improve the identification of high-risk patients for late post stroke seizures. The SeLECT model was the only model developed in line with proposed guidelines for appropriate model development. The model, which was externally validated in a very similar and homogeneous population, may need to be tested in a more racially/ethnic diverse and younger population; testing the SeLECT model, accounting for overall brain health is likely to improve the identification of high-risk patients for late post stroke seizures.Chronic infection with HBV is a major cause of advanced liver disease and hepatocellular carcinoma. Nucleos(t)ide analogues effectively control HBV replication but viral cure is rare. Hence treatment has often to be administered for an indefinite duration, increasing the risk for selection of drug resistant virus variants. PEG-interferon-α-based therapies can sometimes cure infection but suffer from a low response rate and severe side-effects. CHB is characterized by the persistence of a nuclear covalently closed circular DNA (cccDNA), which is not targeted by approved drugs. Targeting host factors which contribute to the viral life cycle provides new opportunities for the development of innovative therapeutic strategies aiming at HBV cure. An improved understanding of the host immune system has resulted in new potentially curative candidate approaches. Here, we review the recent advances in understanding HBV-host interactions and highlight how this knowledge contributes to exploiting host-targeting strategies for a viral cure.